Literature DB >> 5129615

Exchange transfusion with dextran 40 in polycythaemia secondary to hypoxic lung disease.

B D Harrison, R J Gregory, T J Clark, G W Scott.   

Abstract

In eight patients with polycythaemia secondary to hypoxic lung disease 10 elective exchange transfusions were performed to reduce red cell mass, packed cell volume (P.C.V.), and whole blood viscosity. The rationale for reducing P.C.V. is discussed. It is concluded that patients with P.C.V. of 60% or over will benefit from exchange transfusion and that most patients with P.C.V. over 50% and true polycythaemia will also benefit. We also confirm that the technique of exchange transfusion is a rapid, safe, and effective method of achieving large venesections and reducing red cell mass.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5129615      PMCID: PMC1799992          DOI: 10.1136/bmj.4.5789.713

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  Reduction of haematocrit and red-blood-cell volume in patients with polycythaemia secondary to hypoxic lung disease by dapsone and pyrimethamine.

Authors:  C D Pengelly
Journal:  Lancet       Date:  1966-12-24       Impact factor: 79.321

2.  Technique for treatment of polycythaemia by exchange transfusion.

Authors:  R J Gregory
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

3.  Pathogenesis of heart-failure in acute-on-chronic respiratory failure.

Authors:  L Dintenfass; J Read
Journal:  Lancet       Date:  1968-03-16       Impact factor: 79.321

4.  The rapid lowering of haematocrit by exchange transfusion of Rheomacrodex dextran 40. Its use in polycythaemia, cor pulmonale and ischaemic disease.

Authors:  R J Gregory
Journal:  Acta Med Scand       Date:  1971-06

5.  Blood volume changes in chronic bronchitis and emphysema.

Authors:  R Hume
Journal:  Br J Haematol       Date:  1968-08       Impact factor: 6.998

Review 6.  The Veterans Administration cooperative study of pulmonary function. 3. Mortality in relation to respiratory function in chronic obstructive pulmonary disease.

Authors:  A D Renzetti; J H McClement; B D Litt
Journal:  Am J Med       Date:  1966-07       Impact factor: 4.965

7.  Relative viscosity of blood at varying hematocrits in pulmonary circulation.

Authors:  J B Agarwal; R Paltoo; W H Palmer
Journal:  J Appl Physiol       Date:  1970-12       Impact factor: 3.531

8.  Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients.

Authors:  B Burrows; R H Earle
Journal:  N Engl J Med       Date:  1969-02-20       Impact factor: 91.245

9.  Circulatory studies in polycythaemia vera at rest and during exercise.

Authors:  N Segel; J M Bishop
Journal:  Clin Sci       Date:  1967-06       Impact factor: 6.124

10.  The circulation in patients with chronic bronchitis and emphysema at rest and during exercise, with special reference to the influence of changes in blood viscosity and blood volume on the pulmonary circulation.

Authors:  N Segel; J M Bishop
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

View more
  6 in total

1.  Blood viscosity in the newborn.

Authors:  T F Mackintosh; C H Walker
Journal:  Arch Dis Child       Date:  1973-07       Impact factor: 3.791

2.  Clinical features of polycythaemic patients with chronic obstructive non-specific lung disease.

Authors:  J B Cocking; C S Darke
Journal:  Thorax       Date:  1972-07       Impact factor: 9.139

3.  Erythrapheresis in polycythemia.

Authors:  R J Gregory
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-26

Review 4.  Development of secondary polycythaemia in chronic airways obstruction.

Authors:  J R Stradling; D J Lane
Journal:  Thorax       Date:  1981-05       Impact factor: 9.139

5.  Calf blood flow and oxygen carriage after reversal of polycythaemia secondary to hypoxic lung disease.

Authors:  P J Wallis; M C Apps; A C Newland; D W Empey
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

6.  Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease.

Authors:  J A Wedzicha; R M Rudd; M C Apps; F E Cotter; A C Newland; D W Empey
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.